Integrity Alliance’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$311K Buy
+2,184
New +$331K 0.01% 701
2025
Q2
– Sell
-3,124
Closed -$348K – 602
2025
Q1
$348K Buy
+3,124
New +$333K 0.01% 453

Other funds holding NVS

Integrity Alliance's NVS Position: Q3 2026 in Review

Integrity Alliance opened a new position in Novartis (NVS) in Q3 2026: 2,184 shares worth $311K. The stake represents 0.01% of the portfolio and ranks #701 among its holdings. This is a return to the name: Integrity Alliance previously reported a position in NVS as recently as Q1 2025.

Integrity Alliance first reported a position in NVS in Q1 2025 and has held it in 2 quarters since. The position peaked at $348K in Q1 2025. 674 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Integrity Alliance held 2,184 shares of Novartis worth $311K as of Q3 2026.
  • Novartis was a new Integrity Alliance position in Q3 2026.
  • Novartis made up 0.01% of Integrity Alliance's portfolio in Q3 2026, its #701 holding.
  • Integrity Alliance first reported a position in Novartis in Q1 2025 and has held it in 2 quarters since.
  • Integrity Alliance's Novartis position peaked at $348K in Q1 2025.
  • 674 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Integrity Alliance's 13F filing for Q3 2026, filed 29 Oct 2026.